Data From Meta-Analysis Show Victoza(R) Achieved Improved Blood Sugar Control in African-Americans With Type 2 Diabetes
ORLANDO, FL–(Marketwire – 08/04/10) – Novo Nordisk (NYSE: NVO – News ) presented results today demonstrating that once-daily Victoza (liraglutide [rDNA ] injection) achieved significantly greater improvements in blood sugar control compared to placebo among African-American patients with type 2 diabetes. The meta-analysis of phase 3 data from the Liraglutide Effect and Action in Diabetes (LEAD …

Read more on Marketwire via Yahoo! Finance

Tags : , , , , , , , , , , , ,

File under : Uncategorized

Permalink : http://diabetes-type-1.org/uncategorized/data-from-meta-analysis-show-victozar-achieved-improved-blood-sugar-control-in-african-americans-with-type-2-diabetes
Trackback : http://diabetes-type-1.org/uncategorized/data-from-meta-analysis-show-victozar-achieved-improved-blood-sugar-control-in-african-americans-with-type-2-diabetes/trackback

Leave a Reply